PMGC HOLDINGS INC. Accounts Payable and Other Accrued Liabilities, Current
PMGC HOLDINGS INC. (ELAB) had Accounts Payable and Other Accrued Liabilities, Current of $669.38 thousand as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2024-03-29
- 2023-12-31: Accounts Payable and Other Accrued Liabilities, Current $669.38K.
- 2023-09-30: Accounts Payable and Other Accrued Liabilities, Current $705.63M.
- 2022-12-31: Accounts Payable and Other Accrued Liabilities, Current $244.70K; Accounts Payable and Other Accrued Liabilities, Current as first filed $256.32M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-12-31 | $669.38K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $705.63M 10-Q · filed 2023-12-11 | |
| 2022-12-31 | $244.70K 10-K · filed 2024-03-29 | $256.32M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |